In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by Biotechna SA under contract no. 2022/ABM/06/00005-. 00 for co-financing a Commercial Project within the framework of the Competition for the development of targeted or personalised medicine based on therapeutic products based on nucleic acids and small-molecule compounds, the Contracting Authority is carrying out a market survey concerning the cost of purchasing a device for synthesising nanoparticles.
In order to submit an offer, please read the detailed content of the notice on request for quotation 60/2025 and send in the completed offer form.